REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Medilabz Sdn. Bhd. (Malaysia)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Medical and Diagnostic Laboratories | Medical Laboratories
Full name: Medilabz Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Medilabz Sdn. Bhd. is a company in Malaysia, with a head office in Johor Bahru. The company operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. The company was established on January 22, 2021. The company’s latest financial report indicates a net sales revenue drop of 3.58% in 2022. Its’ total assets recorded a growth of 23.7%. In 2022, Medilabz Sdn. Bhd.’s net profit margin decreased by 26.9%.

Headquarters
No 118 (Ground Floor), Jalan Serampang, Taman Pelangi
Johor Bahru; Johor; Postal Code: 80400

Contact Details: Purchase the Medilabz Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Medilabz Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Medilabz Sdn. Bhd. report to view the information.
Incorporation Date:
January 22, 2021
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
70%
Purchase this report to view the information.
30%
Company Performance
Financial values in the chart are available after Medilabz Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-3.58%▼
Total operating revenue
-3.58%▼
Operating profit (EBIT)
-249.3%▼
EBITDA
-277.74%▼
Net Profit (Loss) for the Period
-249.3%▼
Total assets
23.7%▲
Total equity
7.61%▲
Operating Profit Margin (ROS)
-26.9%▼
Net Profit Margin
-26.9%▼
Return on Equity (ROE)
304.52%▲
Quick Ratio
-0.01%▼
Cash Ratio
-0.11%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo